Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG – one of the largest pharmaceutical companies in the world. Novartis is one of Ireland’s leading employers in the healthcare industry. One of the first pharmaceutical companies to locate in Ireland in the 1950s, Novartis has a strong history of investing in Ireland over the last sixty years.
Novartis currently employs approximately 900 people in Dublin. In March 2013, Novartis announced the establishment of the Novartis Corporate Center in Elm Park, Dublin. Novartis Commercial Operations is also based in Elm Park. Novartis’ nationwide presence and flexible working options means there are Novartis employees based all over Ireland.
Novartis has five key therapy areas: Neuroscience, Cardiovascular, Immunology, Oncology and Cell and Gene and Radioligand Therapy. Novartis has a strong pipeline, with more than 100 products in clinical development, and ranks number five in Ireland in terms of number of clinical trials1,2,3,‡.Ireland is a hub of research and development for Novartis, with over 165 Ireland-based R&D employees, and almost €25 million invested by Novartis in Ireland, in this area in 2023. For more information on our products, please go to https://www.medicines.ie
